In-Depth Insights into the Blood Transfusion Diagnostics Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the blood transfusion diagnostics market grown in recent years?
In the past few years, the blood transfusion diagnostics market has experienced a swift expansion. The market size, which stood at $4.42 billion in 2024, is predicted to reach $4.96 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. This significant growth during the historical period is primarily linked with factors such as the rise in blood transfusion procedures, the emergence of new pathogens, an aging population, an escalation in the need for quick blood transfusion diagnostics, an increased prevalence of chronic illnesses, and a heightened demand for blood.
How is the blood transfusion diagnostics market size expected to evolve during the forecast period?
In the coming years, the blood transfusion diagnostics market is projected to witness significant growth, escalating to a value of $6.43 billion by 2029, with a compound annual growth rate (CAGR) of 6.7%. This upward trajectory during the forecast period is largely due to an increased need for precision medicine, increased funds towards blood transfusion infrastructure, a rising demand for molecular blood transfusions, the emergence of infectious diseases, and concerns related to blood safety. Some major trends to look out for during this forecast period are advancements in diagnostics, point-of-care testing, automated systems and robotics, nucleic acid testing (NAT), digital integration, broader pathogen panels, and enhanced testing technologies.
Get your blood transfusion diagnostics market report here!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp
Which key drivers are propelling the blood transfusion diagnostics market’s growth?
Patients who are in the process of having surgical procedures often require blood transfusions to compensate for the blood loss that occurs during this process. Before the transfusion, blood transfusion diagnostics are utilized to screen the blood to prevent the spread of infectious diseases. The US National Library of Medicine and National Institutes of Health reveal in an article that around 310 million surgeries are conducted each year. As a result, the surge in the number of these procedures heightens the demand for blood transfusion diagnostics.
What are the market segments in the blood transfusion diagnostics industry?
The blood transfusion diagnostics market covered in this report is segmented –
1) By Type: Instruments and Kits, Reagents, Other Types
2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test
3) By Application: Blood Grouping, Disease Screening
4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
Subsegments:
1) By Instruments and Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems
2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes and Other Reagents
3) By Other Types: Software Solutions, Consumables, Training And Support Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp
Which leading companies are shaping the growth of the blood transfusion diagnostics market?
Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.
What key trends are currently impacting the blood transfusion diagnostics market’s development?
The rising necessity for sophisticated diagnostic measures and the increasing occurrence of infectious diseases related to pathogens like bacteria and viruses have propelled the preference for nucleic acid amplification testing (NAAT/NAT) as a means to enhance blood safety, increase efficiency, and reduce the time needed for results. NAT is a method that allows detection of a specific nucleic acid, virus, or bacteria that serves as a pathogen in blood, tissue, or urine. Possessing high sensitivity and specificity for viral nucleic acids, NAT amplifies the targeted viral DNA region, thereby detecting these earlier than traditional methods and shortening the duration of infectious diseases. Illustratively, XCRP Diagnostic Inc. and Luminex Corporations formed a licensing agreement for utilizing XCR Diagnostic’s Xtreme Chain Reaction Nucleic Acid Amplification Technology, granting Luminex exclusive rights to use XCR Diagnostic’s NAAT technology in its upcoming molecular diagnostic portfolio.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2494
Which geographic areas are influencing the growth of the blood transfusion diagnostics market?
North America was the largest region in the blood transfusion diagnostics market in 2024. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Blood And Blood Components Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report
Blood Glucose Meters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
Hemodialysis And Peritoneal Dialysis Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
